Investigators at Weill Cornell Medicine have developed a versatile and non-toxic technology for controlling the activity of any gene in a cell. Such "gene-switch" tools allow scientists to "turn on" ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

High-fidelity visualization of a fetal heart is essential for deep understanding about heart myofibers orientation and the ...

Titled “A comparison of integration methods for single‐cell RNA sequencing data and ATAC sequencing data”, this paper ...

New research in Sweden has produced a "blueprint" revealing how the human heart is built during prenatal development. It ...

The global Preclinical Ultrasound Systems Market is on the brink of remarkable transformation, poised to grow from an ...

ATG-022 is a CLDN18.2-targeted ADC with sub-nM affinity and fast internalization. Using a VC-MMAE linker-payload (DAR 4), ATG-022 has demonstrated potent activity across tumors with high, low, and ...

The roles of TET DNA demethylases during early development remain poorly defined. This work uncovers independence of early ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Taysha Gene Therapies ( (TSHA)) just ...

SonoThera ™, a biotechnology company dedicated to treating the root cause of human diseases by developing the next generation of genetic medicines, today announced it will present new data at the 32 ...

For all the investment that pharma makes in engaging patients and providers, the disconnect at the point of care remains stubbornly persistent. Patients and providers routinely enter the exam room ...